Literature DB >> 30796511

Early complications of revision total knee arthroplasty in morbidly obese patients.

Josh Carter1, Bryan Springer1, Brian M Curtin2.   

Abstract

INTRODUCTION: Morbid obesity is a known risk factor for complications and failure following primary total knee arthroplasty. Complications following revision total knee arthroplasty (rTKA) in the morbidly obese (BMI > 40) have not been well described. A retrospective cohort study was designed to investigate the early complications of rTKA in morbidly obese patients.
METHODS: Revision TKA procedures were performed between January 2009 and December 2012 at a single institution. Comparisons were made between patients with a normal BMI (18.5-25) and patients with morbid obesity (BMI > 40).
RESULTS: Thirty-three of 141 morbidly obese patients (23.4%) had a complication compared to 10 of 96 patients with a BMI 18.5-25 (10.4%) (p = 0.011). Morbidly obese patients were younger (69.3 vs. 61.4 years, p < 0.0001), and their most frequent complication in comparison with patients with normal BMI was wound healing problems (p = 0.01).
CONCLUSION: Morbidly obese patients are at a significantly increased rate of early complications following rTKA compared to a normal weight cohort, especially with regard to wound complications. The morbidly obese group was significantly younger at the time of rTKA. In addition, this study highlights the importance of risk stratification for morbidly obese patients undergoing rTKA.

Entities:  

Keywords:  Complications; Morbid obesity; Revision total knee arthroplasty

Mesh:

Year:  2019        PMID: 30796511     DOI: 10.1007/s00590-019-02403-9

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  3 in total

1.  Understanding the 30-day mortality burden after revision total knee arthroplasty.

Authors:  SaTia T Sinclair; Melissa N Orr; Christopher A Rothfusz; Alison K Klika; John P McLaughlin; Nicolas S Piuzzi
Journal:  Arthroplast Today       Date:  2021-10-04

2.  Epidemiology of Obese Patients Undergoing Revision Total Knee Arthroplasty: Understanding Demographics, Comorbidities, and Propensity Weighted Analysis of Inpatient Outcomes.

Authors:  Inaya Hajj Hussein; Abdul Kareem Zalikha; Andrei Tuluca; Zachary Crespi; Mouhanad M El-Othmani
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2022-02-16

3.  Lonafarnib Inhibits Farnesyltransferase via Suppressing ERK Signaling Pathway to Prevent Osteoclastogenesis in Titanium Particle-Induced Osteolysis.

Authors:  Linke Huang; Weiwei Chen; Linhua Wei; Yuangang Su; Jiamin Liang; Haoyu Lian; Hui Wang; Feng Long; Fan Yang; Shiyao Gao; Zhen Tan; Jiake Xu; Jinmin Zhao; Qian Liu
Journal:  Front Pharmacol       Date:  2022-03-01       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.